Skip to search.
 FTSE 100 Up 3.08%

More On AZN

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

  • Profile
  • Key Statistics
  • SEC Filings
  • Competitors
  • Industry
  • Components

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

AstraZeneca PLC (AZN)

-NYSE
29.66 Up 0.51(1.75%) 12 Feb 21:03
Prev Close:29.15
Open:29.18
Bid:29.60 x 100
Ask:29.71 x 100
1y Target Est:35.91
Beta:0.71793
Next Earnings Date:N/A
Day's Range:29.14 - 29.68
52wk Range:28.29 - 36.69
Volume:2,995,676
Avg Vol (3m):4,408,950
Market Cap:74.98b
P/E (ttm):26.60
EPS (ttm):1.12
Div & Yield:0.90 (3.10%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AZNUp 1.75%74.98b
GSKUp 1.56%96.22b
PFEUp 0.79%181.25b
MRKUp 0.37%136.97b

Key Statistics

Forward P/E (1 yr):14.61
P/S (ttm):2.98
Ex-Dividend Date:12-Aug-15

Analysts

Annual EPS Est (Dec-16) :2.06
Quarterly EPS Est (Mar-16) :0.52
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-14.15

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection, and neuroscience diseases worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback